Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans.
As the demand for rabies post-exposure prophylaxis (PEP) treatments has increased exponentially in recent years, the limited supply of human and equine rabies immunoglobulin (HRIG and ERIG) has failed to provide the required passive immune component in PEP in countries where canine rabies is endemic...
Main Authors: | Thomas Müller, Bernhard Dietzschold, Hildegund Ertl, Anthony R Fooks, Conrad Freuling, Christine Fehlner-Gardiner, Jeannette Kliemt, Francois X Meslin, Richard Franka, Charles E Rupprecht, Noël Tordo, Alexander I Wanderler, Marie Paule Kieny |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC2765635?pdf=render |
Similar Items
-
Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans
by: Thomas Müller, et al.
Published: (2009-11-01) -
Correction: Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans.
by: Thomas Müller, et al.
Published: (2009-11-01) -
SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies.
by: Tzu-Yuan Chao, et al.
Published: (2017-12-01) -
Special Issue: Rabies Symptoms, Diagnosis, Prophylaxis, and Treatment
by: Charles E. Rupprecht, et al.
Published: (2017-11-01) -
In Vivo Efficacy of SYN023, an Anti-Rabies Monoclonal Antibody Cocktail, in Post-Exposure Prophylaxis Animal Models
by: Tzu-Yuan Chao, et al.
Published: (2020-02-01)